381 related articles for article (PubMed ID: 9916878)
41. Cerebellar cortical demyelination in the murine cuprizone model.
Skripuletz T; Bussmann JH; Gudi V; Koutsoudaki PN; Pul R; Moharregh-Khiabani D; Lindner M; Stangel M
Brain Pathol; 2010 Mar; 20(2):301-12. PubMed ID: 19371354
[TBL] [Abstract][Full Text] [Related]
42. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model.
Wergeland S; Torkildsen Ø; Myhr KM; Aksnes L; Mørk SJ; Bø L
PLoS One; 2011; 6(10):e26262. PubMed ID: 22028844
[TBL] [Abstract][Full Text] [Related]
43. The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.
Kipp M; Norkus A; Krauspe B; Clarner T; Berger K; van der Valk P; Amor S; Beyer C
Inflamm Res; 2011 Aug; 60(8):723-6. PubMed ID: 21516513
[TBL] [Abstract][Full Text] [Related]
44. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M
J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291
[TBL] [Abstract][Full Text] [Related]
45. TREM2 sustains microglial expansion during aging and response to demyelination.
Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
[TBL] [Abstract][Full Text] [Related]
46. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization.
Chen MK; Baidoo K; Verina T; Guilarte TR
Brain; 2004 Jun; 127(Pt 6):1379-92. PubMed ID: 15069023
[TBL] [Abstract][Full Text] [Related]
47. Reduced cuprizone-induced cerebellar demyelination in mice with astrocyte-targeted production of IL-6 is associated with chronically activated, but less responsive microglia.
Petković F; Campbell IL; Gonzalez B; Castellano B
J Neuroimmunol; 2017 Sep; 310():97-102. PubMed ID: 28778453
[TBL] [Abstract][Full Text] [Related]
48. Evaluation strategy to determine reliable demyelination in the cuprizone model.
Chrzanowski U; Schmitz C; Horn-Bochtler A; Nack A; Kipp M
Metab Brain Dis; 2019 Apr; 34(2):681-685. PubMed ID: 30607821
[TBL] [Abstract][Full Text] [Related]
49. Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.
Schmidt T; Awad H; Slowik A; Beyer C; Kipp M; Clarner T
J Mol Neurosci; 2013 Jan; 49(1):80-8. PubMed ID: 23054589
[TBL] [Abstract][Full Text] [Related]
50. Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination.
Jurevics H; Largent C; Hostettler J; Sammond DW; Matsushima GK; Kleindienst A; Toews AD; Morell P
J Neurochem; 2002 Jul; 82(1):126-36. PubMed ID: 12091473
[TBL] [Abstract][Full Text] [Related]
51. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice.
Irvine KA; Blakemore WF
J Neuroimmunol; 2006 Jun; 175(1-2):69-76. PubMed ID: 16626812
[TBL] [Abstract][Full Text] [Related]
52. Cuprizone feed formulation influences the extent of demyelinating disease pathology.
Toomey LM; Papini M; Lins B; Wright AJ; Warnock A; McGonigle T; Hellewell SC; Bartlett CA; Anyaegbu C; Fitzgerald M
Sci Rep; 2021 Nov; 11(1):22594. PubMed ID: 34799634
[TBL] [Abstract][Full Text] [Related]
53. Inflammatory demyelination alters subcortical visual circuits.
Araújo SES; Mendonça HR; Wheeler NA; Campello-Costa P; Jacobs KM; Gomes FCA; Fox MA; Fuss B
J Neuroinflammation; 2017 Aug; 14(1):162. PubMed ID: 28821276
[TBL] [Abstract][Full Text] [Related]
54. Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice.
Bölcskei K; Kriszta G; Sághy É; Payrits M; Sipos É; Vranesics A; Berente Z; Ábrahám H; Ács P; Komoly S; Pintér E
J Neuroimmunol; 2018 Jul; 320():1-10. PubMed ID: 29759134
[TBL] [Abstract][Full Text] [Related]
55. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.
Matsushima GK; Morell P
Brain Pathol; 2001 Jan; 11(1):107-16. PubMed ID: 11145196
[TBL] [Abstract][Full Text] [Related]
56. Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
Trépanier MO; Hildebrand KD; Nyamoya SD; Amor S; Bazinet RP; Kipp M
J Neurochem; 2018 Jun; 145(6):504-515. PubMed ID: 29574981
[TBL] [Abstract][Full Text] [Related]
57. Citrullinated myelin induces microglial TNFα and inhibits endogenous repair in the cuprizone model of demyelination.
Standiford MM; Grund EM; Howe CL
J Neuroinflammation; 2021 Dec; 18(1):305. PubMed ID: 34961522
[TBL] [Abstract][Full Text] [Related]
58. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter.
Skuljec J; Gudi V; Ulrich R; Frichert K; Yildiz O; Pul R; Voss EV; Wissel K; Baumgärtner W; Stangel M
J Neuropathol Exp Neurol; 2011 Sep; 70(9):758-69. PubMed ID: 21865884
[TBL] [Abstract][Full Text] [Related]
59. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Skripuletz T; Gudi V; Hackstette D; Stangel M
Histol Histopathol; 2011 Dec; 26(12):1585-97. PubMed ID: 21972097
[TBL] [Abstract][Full Text] [Related]
60. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse.
Zhang Y; Xu H; Jiang W; Xiao L; Yan B; He J; Wang Y; Bi X; Li X; Kong J; Li XM
Schizophr Res; 2008 Dec; 106(2-3):182-91. PubMed ID: 18938062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
